Cargando…

The Cost-Effectiveness of Hyperlipidemia Medication in Low- and Middle-Income Countries: A Review

Hyperlipidemia is a risk factor for cardiovascular disease – the leading cause of death globally. Increased understanding of the cost-effectiveness of hyperlipidemia treatment in low- and middle-income countries can guide approaches to hyperlipidemia management in resource-limited environments. We c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Husain, Muhammad Jami, Spencer, Garrison, Nugent, Rachel, Kostova, Deliana, Richter, Patricia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ubiquity Press 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896253/ https://www.ncbi.nlm.nih.gov/pubmed/35342693 http://dx.doi.org/10.5334/gh.1097

Ejemplares similares

The cost-effectiveness of hypertension management in low-income and middle-income countries: a review
por: Kostova, Deliana, et al.
Publicado: (2020)

Introducing the PLOS special collection of economic cases for NCD prevention and control: A global perspective
por: Nugent, Rachel A., et al.
Publicado: (2020)

Correction: Introducing the PLOS special collection of economic cases for NCD prevention and control: A global perspective
por: Nugent, Rachel A., et al.
Publicado: (2020)

Noncommunicable disease-attributable medical expenditures, household financial stress and impoverishment in Bangladesh
por: Datta, Biplab Kumar, et al.
Publicado: (2018)

Building the health-economic case for scaling up the WHO-HEARTS hypertension control package in low- and middle-income countries
por: Moran, Andrew E., et al.
Publicado: (2022)

Blood from a stone: funding hypertension prevention, treatment, and care in low- and middle-income countries
por: Cohn, Jennifer, et al.
Publicado: (2021)

Assessing costs of a hypertension management program: An application of the HEARTS costing tool in a program planning workshop in Thailand
por: Husain, Muhammad Jami, et al.
Publicado: (2019)

Disease and demography: a systems-dynamic cohort-component population model to assess the implications of disease-specific mortality targets
por: Husain, Muhammad Jami, et al.
Publicado: (2021)

Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability
por: Husain, Muhammad Jami, et al.
Publicado: (2020)

Ranking 93 health interventions for low- and middle-income countries by cost-effectiveness
por: Horton, Susan, et al.
Publicado: (2017)

Consumption displacement in households with noncommunicable diseases in Bangladesh
por: Datta, Biplab Kumar, et al.
Publicado: (2018)

Approaches for Controlling Illicit Tobacco Trade — Nine Countries and the European Union
por: Ross, Hana, et al.
Publicado: (2015)

Cost of primary care approaches for hypertension management and risk-based cardiovascular disease prevention in Bangladesh: a HEARTS costing tool application
por: Husain, Muhammad Jami, et al.
Publicado: (2022)

Provider costs for prevention and treatment of cardiovascular and related conditions in low- and middle-income countries: a systematic review
por: Brouwer, Elizabeth D., et al.
Publicado: (2015)

Cost assessment of a program for laboratory testing of plasma trans-fatty acids in Thailand
por: Datta, Biplab Kumar, et al.
Publicado: (2021)

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023)

Low-cost locally manufacturable unilateral imperial external fixator for low- and middle-income countries
por: Saeidi, Mehdi, et al.
Publicado: (2022)

Cost analysis of the WHO-HEARTS program for hypertension control and CVD prevention in primary health facilities in Ethiopia
por: Beshah, Senait Alemayehu, et al.
Publicado: (2023)

Revisiting the association between worldwide implementation of the MPOWER package and smoking prevalence, 2008–2017
por: Husain, Muhammad Jami, et al.
Publicado: (2021)

Strengthening medical specialisation policy in low-income and middle-income countries
por: Sriram, Veena, et al.
Publicado: (2020)

Interventional radiology in low- and middle-income countries
por: Jamil, Hashaam, et al.
Publicado: (2022)

The Impact and Cost of Scaling up Midwifery and Obstetrics in 58 Low- and Middle-Income Countries
por: Bartlett, Linda, et al.
Publicado: (2014)

Psychosocial and pharmacological interventions for personality disorders in low- and middle-income countries: A systematic review
por: Hedemann, Thea Lynne, et al.
Publicado: (2023)

Help and Care Seeking for Sexually Transmitted Infections Among Youth in Low- and Middle-Income Countries
por: Newton-Levinson, Anna, et al.
Publicado: (2017)

Economic Costs of Childhood Lead Exposure in Low- and Middle-Income Countries
por: Attina, Teresa M., et al.
Publicado: (2013)

The cost of dialysis in low and middle-income countries: a systematic review
por: Mushi, Lawrencia, et al.
Publicado: (2015)

Hypertension in women: the role of adolescent childbearing
por: Datta, Biplab K., et al.
Publicado: (2021)

Cost and cost-effectiveness of childhood cancer treatment in low-income and middle-income countries: a systematic review
por: Fung, Alastair, et al.
Publicado: (2019)

Patient-reported outcomes for diabetes and hypertension care in low- and middle-income countries: A scoping review
por: Masyuko, Sarah, et al.
Publicado: (2021)

Cost-effectiveness of club-foot treatment in low-income and middle-income countries by the Ponseti method
por: Grimes, Caris E, et al.
Publicado: (2016)

Strengthening Medical Product Regulation in Low- and Middle-Income Countries
por: Preston, Charles, et al.
Publicado: (2012)

Low-cost alternatives for the management of acute ischemic stroke in low and middle-income countries
por: Nepal, Gaurav, et al.
Publicado: (2021)

Preventing COVID-19 in low- and middle-income countries
por: Khadka, Sitaram, et al.
Publicado: (2020)

Dementia in low- and middle-income countries
por: Graham, Nori
Publicado: (2006)

Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries
por: Linde, Mattias, et al.
Publicado: (2015)

The costs of diabetes treatment in low- and middle-income countries: a systematic review
por: Moucheraud, Corrina, et al.
Publicado: (2019)

Methodology to Forecast Volume and Cost of Cancer Drugs in Low- and Middle-Income Countries
por: Martei, Yehoda M., et al.
Publicado: (2018)

Cost Effectiveness of Environmental Lead Risk Mitigation in Low‐ and Middle‐Income Countries
por: Ericson, Bret, et al.
Publicado: (2018)

Economic costs of childhood stunting to the private sector in low- and middle-income countries
por: Akseer, Nadia, et al.
Publicado: (2022)

Screening for breast cancer: Cost-effective solutions for low- & middle-income countries
por: Mishra, Gauravi A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_74gutqpdsrt7vrrmvlkqc90fek